Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1

Ann Hum Genet. 1995 Jan;59(1):25-37. doi: 10.1111/j.1469-1809.1995.tb01603.x.

Abstract

A novel widely expressed homologue of the VAV oncogene, VAV2 (53% identical residues), has been identified within the critical region for the tuberous sclerosis gene, TSC1, on human chromosome 9q34. By Southern blot analysis, analysis of allele-specific transcription, and direct sequencing of the VAV2 mRNA/cDNA from patient lymphoblastoid cell lines, we demonstrate that both alleles of this gene are expressed in TSC patients and there are no significant mutations. VAV consists of a novel array of signalling domains and is thought to play an important role in signal transduction in haematopoietic tissues where it is exclusively expressed. VAV2 is likely to serve a similar role more generally in mammalian cells, but is not the TSC1 gene.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles
  • Amino Acid Sequence
  • Base Sequence
  • Cell Cycle Proteins*
  • Chromosome Mapping
  • Chromosomes, Human, Pair 9*
  • DNA Mutational Analysis
  • DNA, Complementary / genetics
  • Humans
  • Molecular Sequence Data
  • Oncogene Proteins / genetics*
  • Oncogenes*
  • Organ Specificity
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-vav
  • Sequence Alignment
  • Sequence Homology, Amino Acid
  • Tuberous Sclerosis / genetics*

Substances

  • Cell Cycle Proteins
  • DNA, Complementary
  • Oncogene Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-vav
  • VAV1 protein, human
  • VAV2 protein, human

Associated data

  • GENBANK/S76992